A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9.
Br J Cancer
; 85(8): 1137-46, 2001 Oct 19.
Article
in En
| MEDLINE
| ID: mdl-11710826
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quinone Reductases
/
Aziridines
/
Urinary Bladder Neoplasms
/
Indolequinones
/
Indoles
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Br J Cancer
Year:
2001
Document type:
Article
Affiliation country:
United kingdom